CL2E-SN38 TFA, a structurally stable and highly releasable antibody drug conjugate (ADC), comprises SN-38, the active metabolite of Irinotecan derived from camptothecins, known for its Topoisomerase I inhibitory activity.
Molekulargewicht:
1855.95
Reinheit:
99.88%
Formel:
C89H117F3N14O26
Target-Kategorie:
Drug-Linker Conjugates for ADC
T77837
T77837
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten